BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

492 related articles for article (PubMed ID: 15920505)

  • 1. Environmental enrichment reverses behavioral alterations in rats prenatally exposed to valproic acid: issues for a therapeutic approach in autism.
    Schneider T; Turczak J; Przewłocki R
    Neuropsychopharmacology; 2006 Jan; 31(1):36-46. PubMed ID: 15920505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism.
    Schneider T; Przewłocki R
    Neuropsychopharmacology; 2005 Jan; 30(1):80-9. PubMed ID: 15238991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender-specific behavioral and immunological alterations in an animal model of autism induced by prenatal exposure to valproic acid.
    Schneider T; Roman A; Basta-Kaim A; Kubera M; Budziszewska B; Schneider K; Przewłocki R
    Psychoneuroendocrinology; 2008 Jul; 33(6):728-40. PubMed ID: 18396377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tactile stimulation improves neuroanatomical pathology but not behavior in rats prenatally exposed to valproic acid.
    Raza S; Harker A; Richards S; Kolb B; Gibb R
    Behav Brain Res; 2015 Apr; 282():25-36. PubMed ID: 25557797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Environmental enrichment attenuates behavioral abnormalities in valproic acid-exposed autism model mice.
    Yamaguchi H; Hara Y; Ago Y; Takano E; Hasebe S; Nakazawa T; Hashimoto H; Matsuda T; Takuma K
    Behav Brain Res; 2017 Aug; 333():67-73. PubMed ID: 28655565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal model of autism induced by prenatal exposure to valproate: behavioral changes and liver parameters.
    Bambini-Junior V; Rodrigues L; Behr GA; Moreira JC; Riesgo R; Gottfried C
    Brain Res; 2011 Aug; 1408():8-16. PubMed ID: 21767826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of ketogenic diet in an animal model of autism induced by prenatal exposure to valproic acid.
    Castro K; Baronio D; Perry IS; Riesgo RDS; Gottfried C
    Nutr Neurosci; 2017 Jul; 20(6):343-350. PubMed ID: 26856821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The histamine H3R antagonist DL77 attenuates autistic behaviors in a prenatal valproic acid-induced mouse model of autism.
    Eissa N; Jayaprakash P; Azimullah S; Ojha SK; Al-Houqani M; Jalal FY; Łażewska D; Kieć-Kononowicz K; Sadek B
    Sci Rep; 2018 Aug; 8(1):13077. PubMed ID: 30166610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-2-ene-valproic acid is less behaviorally teratogenic than an equivalent dose of valproic acid in rats.
    Fisher JE; Acuff-Smith KD; Schilling MA; Nau H; Vorhees CV
    Teratology; 1994 Jun; 49(6):479-86. PubMed ID: 7747269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of pioglitazone, a selective peroxisome proliferator-activated receptor-γ agonist in prenatal valproic acid-induced behavioral and biochemical autistic like features in Wistar rats.
    Mirza R; Sharma B
    Int J Dev Neurosci; 2019 Aug; 76():6-16. PubMed ID: 31128204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex difference in cognitive behavioral alterations and barrel cortex neuronal responses in rats exposed prenatally to valproic acid under continuous environmental enrichment.
    Sabzalizadeh M; Mollashahi M; Afarinesh MR; Mafi F; Joushy S; Sheibani V
    Int J Dev Neurosci; 2022 Oct; 82(6):513-527. PubMed ID: 35738908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased hippocampal cell density and enhanced spatial memory in the valproic acid rat model of autism.
    Edalatmanesh MA; Nikfarjam H; Vafaee F; Moghadas M
    Brain Res; 2013 Aug; 1526():15-25. PubMed ID: 23806776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal pregabalin is associated with sex-dependent alterations in some behavioral parameters in valproic acid-induced autism in rat offspring.
    Shamsi Meymandi M; Sepehri G; Moslemizadeh A; Vakili Shahrbabaki S; Bashiri H
    Int J Dev Neurosci; 2020 Oct; 80(6):500-511. PubMed ID: 32588482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benefits of Fenofibrate in prenatal valproic acid-induced autism spectrum disorder related phenotype in rats.
    Mirza R; Sharma B
    Brain Res Bull; 2019 Apr; 147():36-46. PubMed ID: 30769127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male-specific alteration in excitatory post-synaptic development and social interaction in pre-natal valproic acid exposure model of autism spectrum disorder.
    Kim KC; Kim P; Go HS; Choi CS; Park JH; Kim HJ; Jeon SJ; Dela Pena IC; Han SH; Cheong JH; Ryu JH; Shin CY
    J Neurochem; 2013 Mar; 124(6):832-43. PubMed ID: 23311691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
    Hajheidari S; Miladi-Gorji H; Bigdeli I
    Neurosci Lett; 2015 Sep; 605():39-43. PubMed ID: 26275348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential Local Connectivity and Neuroinflammation Profiles in the Medial Prefrontal Cortex and Hippocampus in the Valproic Acid Rat Model of Autism.
    Codagnone MG; Podestá MF; Uccelli NA; Reinés A
    Dev Neurosci; 2015; 37(3):215-31. PubMed ID: 25895486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonexploratory movement and behavioral alterations in a thalidomide or valproic acid-induced autism model rat.
    Narita M; Oyabu A; Imura Y; Kamada N; Yokoyama T; Tano K; Uchida A; Narita N
    Neurosci Res; 2010 Jan; 66(1):2-6. PubMed ID: 19755133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of early handling on anxiety-like behaviors of rats exposed to valproic acid pre-and post-natally.
    Shafaghi A; Vakili Shahrbabaki SS; Aminzadeh A; Heidari MR; Shamsi Meymandi M; Bashiri H
    Neurotoxicol Teratol; 2022; 89():107050. PubMed ID: 34801733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of "enriched environment" during development on adult rat behavior and response to the dopamine receptor agonist apomorphine.
    Hoffmann LC; Schütte SR; Koch M; Schwabe K
    Neuroscience; 2009 Feb; 158(4):1589-98. PubMed ID: 19110038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.